Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains

Yelda Demir1, Yasemin Zer1, Ilkay Karaoglan2

  • 1Department of Medical Microbiology, Medical Faculty, Gaziantep University, Gaziantep, Turkey.

Insights

Carbapenemase genes, particularly OXA-48, are prevalent in Enterobacteriaceae causing hospital infections. Identifying these carbapenem-resistant Enterobacteriaceae (CRE) is crucial for effective treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Gram-negative bacteria, especially Enterobacteriaceae, are a growing cause of nosocomial infections.
  • Carbapenem resistance in these bacteria poses a significant treatment challenge.
  • Carbapenemases are frequently identified in Enterobacteriaceae strains.

Purpose of the Study:

  • To detect and characterize carbapenemase genes in Enterobacteriaceae isolated from clinical samples.
  • To investigate the prevalence of specific carbapenemase types, including VIM, IMP, NDM-1, KPC, and OXA-48.

Main Methods:

  • Enterobacteriaceae isolates were obtained from various clinical specimens (urine, blood, respiratory, wound).
  • Antimicrobial susceptibility testing was performed for imipenem, meropenem, and ertapenem.
  • Carbapenemase gene detection was conducted using the HyplexSuperBug ID kit.

Main Results:

  • Ninety-five Enterobacteriaceae isolates were analyzed. Of these, 60 were resistant to all tested carbapenems, 20 showed intermediate resistance, and 15 were susceptible.
  • Carbapenemase genes were detected in 57 of the resistant isolates; susceptible isolates lacked these genes.
  • OXA-48 was the most common carbapenemase gene, found in 49 isolates (86%), followed by NDM-1 in 6 isolates (10.5%) and VIM in 2 isolates. IMP and KPC genes were not detected.

Conclusions:

  • Carbapenemase genes are critical drivers in the emergence and dissemination of carbapenem-resistant Enterobacteriaceae.
  • The high prevalence of OXA-48 highlights its importance in hospital-acquired infections caused by Enterobacteriaceae.
  • Molecular detection of carbapenemase genes is essential for guiding antimicrobial therapy and infection control.